Inventor · disambiguated record
Ramachandran Thirucote
Also filed as: THIRUCOTE RAMACHANDRAN
9 granted patents·13 pending applications·30 citations·filing 2005–2021
86Inventor score
Files withUNIV WESTERN HEALTH SCIENCES7WHITING ROGER4LUITPOLD PHARM INC3ROXRO PHARMA INC2TESORX PHARMA LLC2
Top patents by PatentIndex Score
22 records- 0184US9844557B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2016·Granted Dec 19, 2017·4 cites·17 claims
- 0283US9445995B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2015·Granted Sep 20, 2016·4 cites·11 claims
- 0383US8277781B2Device for intranasal administrationWHITING ROGER·Filed 2009·Granted Oct 2, 2012·7 cites·6 claims
- 0482US9629894B2Magnesium-containing oxytocin formulations and methods of useTRIGEMINA INC·Filed 2016·Granted Apr 25, 2017·6 cites·24 claims
- 0580US8957053B2Proliposomal testosterone formulationsBETAGERI GURU V·Filed 2014·Granted Feb 17, 2015·4 cites·20 claims
- 0679US9623033B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2016·Granted Apr 18, 2017·2 cites·13 claims
- 0765US11389473B2Magnesium-containing oxytocin formulations and methods of useTONIX Pharmaceuticals Holding Corp·Filed 2016·Granted Jul 19, 2022·1 cites·24 claims
- 0863US2010016402A1Unit dose formulations of ketorolac for intranasal administrationROXRO PHARMA INC·Filed 2009·Application pending·0 cites
- 0961US8551454B2Device for intranasal administrationWHITING ROGER·Filed 2010·Granted Oct 8, 2013·2 cites·7 claims
- 1059US2018303850A1Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 1158US2017173277A1Device for intranasal administrationWHITING ROGER·Filed 2017·Application pending·0 cites
- 1255US2021267896A1Formulations for treating bladder cancerUNIV WESTERN HEALTH SCIENCES·Filed 2021·Application pending·0 cites
- 1354US11229602B2Formulations for treating bladder cancerUNIV WESTERN HEALTH SCIENCES·Filed 2017·Granted Jan 25, 2022·0 cites·16 claims
- 1453US2013000634A1Device for intranasal administrationLUITPOLD PHARM INC·Filed 2012·Application pending·0 cites
- 1551US2009042968A1Therapeutic compositions for intranasal administration of ketorolacROXRO PHARMA INC·Filed 2005·Application pending·0 cites
- 1651US2012329849A1Unit dose formulations of ketorolac for intranasal administrationWHITING ROGER·Filed 2012·Application pending·0 cites
- 1749US2015314084A1Device for intranasal administrationLUITPOLD PHARM INC·Filed 2015·Application pending·0 cites
- 1849US2013186391A1Device for intranasal administration of ketorolacLUITPOLD PHARM INC·Filed 2013·Application pending·0 cites
- 1947US2016136089A1Unit dose formulations of ketorolac for intranasal administrationEGALET US INC·Filed 2015·Application pending·0 cites
- 2042US2022265679A1Proliposomal testosterone undecanoate formulationsTESORX PHARMA LLC·Filed 2020·Application pending·0 cites
- 2135US2022000777A1Liposomal enhanced intra-peritoneal chemotherapyTESORX PHARMA LLC·Filed 2019·Application pending·0 cites
- 2232US2019248830A1Proliposomal testosterone undecanoate formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →